吗啡诱导的反应性氧物种的升高减弱了化学疗法在各种癌症细胞类型的疗效
Gong Chen1, Si Zeng2, Bin Wang1
1Department of Anesthesiology, Baoan Central Hospital of Shenzhen, Shenzhen, Guangdong Province, China.
Current molecular medicine
|January 16, 2025
概括
在癌症患者中使用吗啡可能会通过增加氧化应激和癌细胞耐药性来降低化疗的有效性,独立于片受体. 抗氧化剂可能会抵消这种效应.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 癌症研究 癌症研究
背景情况:
- 吗啡是一种片受体 (MOR) 激动剂,用于治疗癌症疼痛.
- 它对癌症的影响是复杂的,并因癌症类型和剂量而异.
- 这项研究调查了吗啡对不同癌症模型的影响.
研究的目的:
- 系统地评估和比较吗啡对三种临床前癌症模型的影响.
- 为了确定吗啡是否会影响化疗疗效.
- 为了阐明吗啡观察到的影响背后的机制.
主要方法:
- 用吗啡,化疗或组合治疗癌症细胞系.
- 进行了细胞活力和亡试验.
- 测量了氧化应激标志物 (ROS,超氧化失突酶,催化酶),并使用抗氧化剂进行了救援研究.
主要成果:
- 吗啡 (以非细胞毒剂量) 降低了卵巢,甲状腺和口腔癌的化疗疗效.
- 这种效应独立于片受体 (MOR) 和特定的化疗剂.
- 吗啡增加了活性氧物种 (ROS) 和抑制了抗氧化酶,这种效应被抗氧化剂逆转.
结论:
- 吗啡可以诱导各种癌症类型的化学抵抗.
- 该机制涉及增加的氧化应激,并且独立于MOR.
- 这些发现可能会为在接受化疗的癌症患者中临床使用吗啡提供信息.
相关概念视频
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Electron Transport Chain: Complex I and II
10.8K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
10.8K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


